FDA Speeds Up Rare Kid Med with Magic Voucher System
Published Date: 1/21/2026
Notice
Summary
The FDA just approved RHAPSIDO (remibrutinib) using a special Rare Pediatric Disease Priority Review Voucher, speeding up its review because it treats a rare childhood illness. This helps companies get their important medicines to kids faster and encourages more rare disease research. The approval happened on September 30, 2025, and signals ongoing support for rare pediatric treatments.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
RHAPSIDO Approved for Rare Pediatric Use
The FDA approved RHAPSIDO (remibrutinib) on September 30, 2025, as a product that redeemed a Rare Pediatric Disease Priority Review Voucher. If your child has the rare pediatric condition this drug treats, this approval means an FDA-approved treatment is now available.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20663, Agency Information Collection Activities; Proposed Collection; Comment Request; Channels of Trade Policy for Commodities With Residues of Pesticide Chemicals, for Which Tolerances Have Been Revoked, Suspended, or Modified by the Environmental Protection Agency Pursuant to Dietary Risk Considerations
The FDA wants your thoughts on how they collect info about food products that might have tiny amounts of banned or changed pesticides. This affects farmers, food sellers, and anyone handling these foods, making sure safety rules keep up with new pesticide limits. You’ve got until December 7, 2026, to share your views—no cost, just your voice!
Previous / Next Documents
Previous: 2026-01081, Combined Notice of Filings #1
The Federal Energy Regulatory Commission got several new filings from energy companies like Duke Energy and PJM Interconnection. These filings include requests to change rates, update agreements, and certify new energy projects. If you’re involved in energy or power, watch for comment deadlines in early February and possible changes to how energy costs and projects are handled.
Next: 2026-01085, Formations of, Acquisitions by, and Mergers of Bank Holding Companies
Some companies want to become or grow as bank holding companies by merging or buying other banks. If you’re involved in banking or just curious, you can share your thoughts by February 20, 2026. These moves could shake up local banking and might affect how money flows in your community.